This is one of the most emotionally devastating experiences in fertility medicine. And one of the most common explanations — one that standard ICSI cannot detect and therefore cannot correct — lies inside the sperm itself. Not in its shape. Not in its swimming speed. Inside its nucleus. In structures so small they are completely invisible at the magnification levels used by standard ICSI.
IMSI — Intracytoplasmic Morphologically-Selected Sperm Injection — is the technology that closes this gap. By examining each sperm at magnifications of 6,000× to 10,000× using a specialised Nomarski Differential Interference Contrast (DIC) microscope, our embryologists at Wellspring IVF can see what standard ICSI cannot: nuclear vacuoles — the hidden craters inside the sperm head that signal DNA damage, chromatin disruption, and chromosomal instability.
For couples who have suffered unexplained ICSI failure, recurrent miscarriage with apparently normal embryos, or who carry a diagnosis of high Sperm DNA Fragmentation (DFI), IMSI is not an optional upgrade. It is the scientifically justified next step.
To understand IMSI, you must first understand what nuclear vacuoles are — and why their presence in a sperm is clinically significant enough to reject that sperm from injection.
Nuclear vacuoles are indentations, cavities, or abnormal inclusions within the sperm nucleus — the compartment of the sperm head that contains the genetic material (chromosomes and DNA). Under standard ICSI magnification (200–400×), the sperm head appears as a smooth, oval shape. At 6,000–10,000× under Nomarski DIC microscopy, the internal architecture of the nucleus becomes visible — and in many sperm that appear perfectly normal externally, dark areas called vacuoles become apparent.
Research from multiple reproductive medicine centres has established a clinically important correlation between nuclear vacuoles — particularly large nuclear vacuoles (LNV) — and sperm DNA integrity. Studies published in peer-reviewed journals including Human Reproduction and Fertility & Sterility have demonstrated:
Sperm DNA Fragmentation testing (DFI / SCSA / TUNEL) measures the overall percentage of damaged sperm in the ejaculate. A man can have a DFI of 30% — meaning 30% of his sperm carry DNA damage — but his standard semen analysis shows ‘normal’ morphology and motility. Why? Because semen analysis morphology is assessed at 400× — the same level as ICSI selection. Nuclear vacuoles are invisible at this magnification. The damaged sperm looks identical to the healthy sperm when examined at standard resolution.
Learn how IMSI treatment works, when it may be recommended, and what couples can expect during the process.
Learn how IMSI treatment helps improve sperm selection and IVF success in certain male infertility cases.
Differential Interference Contrast microscopy — developed by Polish-born physicist Georges Nomarski in the 1950s — uses polarised light and a birefringent (double-refracting) prism to create interference between two beams of light passing through the specimen at slightly different angles. The result is a pseudo-three-dimensional, high-contrast image of the internal optical density variations within the specimen — without requiring staining or any chemical treatment that would damage the sperm.
Applied to sperm at 6,000–10,000× digital magnification, Nomarski DIC microscopy reveals the internal nuclear architecture that is entirely invisible under standard brightfield optics. The difference in image quality is not marginal — it is transformational.
| Microscopy Property | Standard ICSI (Brightfield) vs IMSI (Nomarski DIC) |
|---|---|
| Optical principle | Standard transmitted light — no interference contrast |
| Magnification at selection | 200–400× — basic shape and motility assessment only |
| Nuclear architecture visible? | No — nucleus appears as uniform grey oval |
| Vacuole detection | Impossible — vacuoles invisible at this resolution |
| Requires special equipment? | No — standard micromanipulation microscope |
| Sperm assessment time | 30–60 seconds per egg — rapid selection |
| Microscopy Property | Standard ICSI (Brightfield) vs IMSI (Nomarski DIC) |
|---|---|
| Optical principle | Standard transmitted light — no interference contrast |
| Magnification at selection | 200–400× — basic shape and motility assessment only |
| Nuclear architecture visible? | No — nucleus appears as uniform grey oval |
| Vacuole detection | Impossible — vacuoles invisible at this resolution |
| Requires special equipment? | No — standard micromanipulation microscope |
| Sperm assessment time | 30–60 seconds per egg — rapid selection |
Under IMSI, each sperm’s nuclear quality is assigned a grade based on the number, size, and location of vacuoles observed. At Wellspring IVF, only Grade 0 and Grade 1 sperm are selected for injection:
Grade 0 Clean Nucleus No vacuoles detected. Optimal nuclear integrity. ✅ SELECTED | Grade 1 Minor Vacuole Small vacuole <4% of nuclear area. Acceptable quality. ✅ SELECTED | Grade 2 Moderate Vacuoles 4–13% of nuclear area. Avoided when possible. ⚠️ AVOIDED | Grade 3 Large Vacuoles LNV >13% of nuclear area. Strong DNA damage association. ❌ REJECTED |
Comparison Point | ICSI | IMSI |
Sperm selection magnification | 200–400× | 6,000–10,000× |
Microscopy type | Standard brightfield | Nomarski DIC (Differential Interference Contrast) |
Nuclear vacuole detection | Not possible | Direct visual assessment per sperm |
DNA damage identification | Indirect — via DFI test on sample | Individual sperm — vacuolated sperm rejected before injection |
Injection technique | Micropipette — standard ICSI injection | Identical micropipette technique — selection is the difference |
Time per egg | 30–60 seconds | 3–5 minutes — thorough nuclear evaluation |
Equipment required | Standard micromanipulation system | Dedicated Nomarski DIC micromanipulation setup |
Best for | Most IVF / ICSI cases | Recurrent failure, high DFI, severe teratospermia, recurrent miscarriage |
Available at Wellspring | Yes — all cycles | Yes — on clinical indication, in-house equipment |
Dr. Pranay Shah recommends IMSI selectively — based on a review of the couple’s complete history, semen analysis, previous cycle data, and DFI results — not as a routine add-on for every cycle. The following are the primary clinical scenarios where IMSI is evidence-supported and strongly considered:
When two or more ICSI cycles have produced good embryos that failed to implant, or when blastocyst development has been consistently poor despite adequate egg numbers and apparently normal semen parameters, sperm nuclear quality is a plausible undetected contributor. IMSI provides the deeper level of sperm evaluation that the previous cycles could not offer.
When pregnancies have been achieved after ICSI but ended in early miscarriage — particularly recurrent miscarriage where chromosomal analysis of the loss shows embryonic chromosomal abnormality — nuclear vacuoles in the sperm may have been contributing to chromosomal instability in the resulting embryos.
DFI testing establishes that a significant proportion of the sperm sample carries DNA damage. IMSI provides the means to identify and avoid the individual sperm carrying that damage — a capability that standard ICSI and standard DFI testing cannot provide individually. The combination of DFI > 25% with previous cycle failure is one of the strongest indications for IMSI.
When sperm morphology is severely abnormal — normal forms below 1% on Kruger strict criteria — the proportion of sperm carrying nuclear vacuoles is significantly higher than in men with normal morphology. IMSI provides the additional selection layer to identify the rare structurally sound sperm within a severely compromised sample.
When previous ICSI cycles have produced embryos that consistently show high fragmentation, early developmental arrest, or failure to reach blastocyst stage — despite good egg quality — sperm nuclear integrity is a possible unexplored factor. IMSI addresses this variable directly.
Sperm DNA damage and nuclear vacuole prevalence increase with paternal age. For couples where the male partner is above 40 and the couple has experienced unexplained ICSI outcomes, IMSI provides an additional layer of selection precision that becomes progressively more relevant with advancing paternal age.
The IMSI procedure is performed on the morning of egg retrieval (Ovum Pick-Up / OPU), at the same time as standard ICSI would be performed. From the patient’s perspective, the IMSI cycle is identical to a standard ICSI cycle — the difference lies entirely within the embryology laboratory, in the sperm selection step that precedes injection.
On the morning of OPU, the male partner provides a semen sample (or the pre-frozen / surgically retrieved sample is thawed). The sample undergoes density gradient centrifugation and swim-up processing — identical preparation to standard ICSI. The resulting washed sperm preparation is placed under the Nomarski DIC microscope for IMSI selection rather than under a standard brightfield microscope.
Under 6,000–10,000× Nomarski DIC magnification, the embryologist systematically evaluates each sperm in the preparation. Shape, nuclear architecture, vacuole presence, vacuole grade (0–3), and vacuole location within the nucleus are all assessed for each candidate sperm. This evaluation takes 3–5 minutes per egg — significantly longer than standard ICSI selection — reflecting the depth of assessment being performed.
Only sperm graded Grade 0 (no vacuoles) or Grade 1 (minor vacuole <4% of nuclear area) are selected for injection. Grade 2 and Grade 3 sperm are systematically rejected. If the sample is severely compromised and Grade 0/1 sperm are scarce, the embryologist identifies the highest-quality sperm available — this clinical reality is discussed with patients beforehand for very severe teratospermia cases.
Once an optimal sperm is selected under IMSI magnification, the injection step proceeds using the identical micropipette technique as standard ICSI. The sperm is immobilised and injected directly into the egg cytoplasm. The higher magnification used for selection does not alter the injection mechanics — the embryologist moves between the DIC microscope and the injection setup with precision timing to maintain egg viability throughout.
Post-injection, the fertilised eggs are cultured identically to a standard ICSI cycle — in Wellspring’s advanced incubation system with controlled temperature, CO₂, and humidity. Fertilisation confirmation (2PN) is assessed the following morning. Embryo development is monitored to Day 5 for blastocyst formation. IMSI aims to improve blastocyst development rates and embryo quality at this stage — this is where the benefit of superior sperm selection becomes measurable.
What Patients Experience — No Difference from a Standard ICSI CycleStimulation injections, follicular monitoring, OPU (egg retrieval), and embryo transfer are all identical to a standard ICSI cycle. The female partner does not undergo any additional procedures for IMSI. The male partner provides the semen sample in the same way as for standard ICSI. IMSI adds time to the embryology laboratory process — not to the patient’s treatment protocol. Results — fertilisation rate, Day 5 embryo quality, and transfer outcome — are reviewed with Dr. Pranay Shah and explained in full at every update call. |
Our fertility specialists are committed to providing personalized, compassionate care with
the latest reproductive medicine techniques.
Outcome Measure | IMSI vs ICSI Comparison |
Blastocyst formation rate | Studies report 5–15% improvement in blastocyst development rates in indicated patients |
Clinical pregnancy rate (indicated cases) | Reported improvement of 8–20% in patients with recurrent ICSI failure or high DFI |
Miscarriage rate | Reduced in studies examining teratospermia and high vacuole populations — exact reduction varies by study |
Time investment per cycle | IMSI adds 2–4 hours to the embryology session vs standard ICSI — accounted for in scheduling |
Where IMSI shows NO advantage | Normal semen parameters + first IVF cycle + no prior failure: ICSI performs comparably |
IMSI is clinically valuable and evidence-supported. But the fertilised embryo still needs to develop, implant, and be carried to term — processes influenced by many additional factors including female age, uterine receptivity, and embryo chromosomal status.
Dr. Pranay Shah will give you a realistic, personalised assessment of what IMSI can and cannot change in your specific clinical context. We do not oversell technical add-ons. We recommend them only when the evidence and your clinical profile align.
IMSI | PICSI | |
|---|---|---|
Selection basis | Nuclear morphology — visual vacuole assessment at 6,600× | Hyaluronan binding — biochemical maturity and receptor surface test |
What it detects | Internal nuclear defects (vacuoles) visible under DIC optics | Sperm maturity and DNA integrity via biochemical binding affinity |
Primary use case | Teratospermia, recurrent failure, poor embryo quality | High DFI, recurrent implantation failure, advanced paternal age |
Used together? | Yes — PICSI pre-selects mature sperm, IMSI then visually confirms nuclear quality before injection | Yes — complementary layers of selection for the most complex cases |
For patients with both severely abnormal morphology AND high DFI, a combined approach using PICSI for pre-selection followed by IMSI for final visual nuclear confirmation may be recommended. Dr. Shah will advise based on your specific laboratory results. For the full PICSI explanation, see the advanced sperm selection section of our ICSI treatment guide.
No — the published evidence is clear on this. IMSI shows consistent benefit in specific patient populations: recurrent ICSI failure, high sperm DNA fragmentation, severe teratospermia, and recurrent miscarriage with apparently normal embryos. For patients having their first IVF/ICSI cycle with normal semen parameters, the evidence does not support IMSI as a universal upgrade over standard ICSI. Dr. Pranay Shah recommends IMSI on clinical indication — not as a routine add-on.
Yes. Standard semen analysis morphology is assessed at 400× magnification — the same level as standard ICSI selection. Nuclear vacuoles are completely invisible at this resolution. A man can have ‘normal’ morphology on a standard semen analysis and still have a significant proportion of sperm with nuclear vacuoles visible under IMSI magnification. This is one of the most important points about IMSI — it reveals what standard morphology assessment structurally cannot.
IMSI uses the same injection technique as ICSI — the only difference is the microscope used for sperm selection. The injection itself carries the same small risk of egg degeneration (1–3%) as standard ICSI. IMSI does not increase this risk. The additional time spent on sperm selection is managed by our experienced embryology team, and eggs are maintained in optimal culture conditions throughout the extended selection process.
Not automatically — but it is a serious consideration. Before recommending IMSI, Dr. Pranay Shah would want to review the previous clinic’s embryology data (fertilisation rate, embryo grades, blastocyst development), your DFI result, both partners’ karyotypes, and your complete clinical history. IMSI addresses one specific potential source of failure. If the previous cycles produced poor blastocyst development, sperm nuclear quality is a plausible contributor. If the previous cycles produced good blastocysts that failed to implant, female receptivity factors should be investigated alongside IMSI — an ERA test may be relevant. A holistic evaluation comes first.
IMSI and PICSI assess different properties — they are not competing technologies. IMSI evaluates nuclear morphology visually at ultra-high magnification. PICSI selects sperm based on biochemical hyaluronan-binding ability. For some patients — particularly those with both severely abnormal morphology AND high DFI — a combined approach using PICSI for pre-selection followed by IMSI for final visual nuclear confirmation may be recommended by Dr. Shah based on your specific results.
IMSI involves specialised Nomarski DIC equipment, longer embryologist time, and specific technical expertise beyond standard ICSI. A complete, itemised cost breakdown is provided at your consultation with Dr. Pranay Shah. For current pricing, contact our team directly at +91 9099946050. We do not add charges without explaining exactly what each element covers.
No, current medical studies show that IMSI does not increase the risk of congenital abnormalities or genetic defects compared to standard IVF or ICSI. In fact, because IMSI allows our embryologists to actively screen out and reject sperm with severe structural and nuclear defects—which are often linked to high DNA fragmentation and chromosomal instability—the goal is to select the healthiest possible genetic material for fertilization. The injection procedure itself is identical to standard ICSI; only the precision of the selection process is enhanced.
